BNB Plus Nets $1.2 Million Accelerated LineaDNA Order, Largest to Date

BNB Plus reports a $1.2M LineaDNA order accelerating procurement to five months, the largest LineaDNA sale to date, with H1 2026 shipments planned to IVD and biotherapeutics markets.

Rich by Coin

2026-01-05

BNB Plus Corp. (Nasdaq: BNBX) announced that it has received a $1.2 million USD order for LineaDNA, the largest LineaDNA order in the company’s history. The order accelerates an existing customer’s annual purchasing cadence, consolidating what was planned as a two-year cycle into a delivery schedule expected to be completed by May 2026. The order was placed by a global manufacturer of in vitro diagnostics under an existing supply agreement.

The company noted that it had previously announced LineaDNA purchases by this customer, including a $600,000 USD follow-on order in July 2025. The latest order reflects the customer’s decision to accelerate procurement, delivering within five months instead of the typical two-year cycle.

Including the recent order, BNBX expects to ship over $1.5 million of LineaDNA to customers in the IVD and biotherapeutic markets in the first half of 2026. The announcement underscores the company’s ongoing execution in meeting large LineaDNA orders. Additionally, the company recently announced that it successfully manufactured and shipped a LineaDNA order valued at over $390,000 USD.